2024-10-22 15:35:12
Swiss Pharma Company - IDEOGEN takes over Special Access Program for BELEODAQ® (belinostat)
Health/ 2023-07-22
Swiss Pharma Company - IDEOGEN takes ove...

HURDEN,Switzerland,Jan. 22,2022-- IDEOGEN GROUP,Managed Access division,takes over Special Access Program for BELEODAQ® (belinostat) in ...

Innovent and Eli Lilly and Company Announced Final Clinical Results and Biomarker Analysis of Phase Ib Study of TYVYT® (Sintilimab Injection) Plus Bevacizumab Biosimilar Injection for Advanced Hepatocellular Carcinoma at ASCO GI Annual Meeting 2022
Corporate/ 2023-07-24
Innovent and Eli Lilly and Company Annou...

SAN FRANCISCO and SUZHOU,China,Jan. 22,2022-- Innovent Biologics,Inc. ("Innovent",HKEX: 01801),a world-class biopharmaceutical com...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release